Neumora Therapeutics, Inc. (NMRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $69.43M
Last updated: Nov 17, 2026 at 4:17 PM ET
Neumora Therapeutics, Inc. (NMRA) Stock Chart
Neumora Therapeutics (NMRA) has a latest price of $0.33 on Nov 17, 2026, 90.8% below its 52-week high of $3.65. Its price fell 87.4% over the past 12 months. The month-end price fell 96.6% over the 3 years through Oct 2026, a compound annual decline of 67.7%.
Price Chart
From Sep 2023 to Oct 2026, its highest month-end close was $17.63 in Feb 2024 and its lowest $0.37 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NMRA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NMRA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 79.6%, and over 6 months it fell 80.0%.
| Period | Change |
|---|---|
| 1 month | -28.8% |
| 3 months | -79.6% |
| 6 months | -80.0% |
| 12 months | -87.4% |
| 12 months, with dividends | -87.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.6% | -67.7% |
Price by Year
Its best calendar year was 2024, when the price fell 37.8%, and its weakest was 2025, when it fell 83.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.37 | -79.5% |
| 2025 | $1.79 | -83.1% |
| 2024 | $10.60 | -37.8% |
Trading Range
The price is 40.7% below its 50-day average of $0.56 and 80.2% below its 200-day average of $1.69.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.33 | |
| 52-week high | $3.65 | -90.8% |
| 52-week low | $0.32 | +6.2% |
| 50-day average | $0.56 | -40.7% |
| 200-day average | $1.69 | -80.2% |
Price Risk
Over 3 years, its largest fall from a peak was 98.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.74 |
| Largest fall, 1 year | -90.7% |
| Largest fall, 3 years | -98.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NMRA
What is NMRA's 1-year price change?
Neumora Therapeutics's price fell 87.4% over the past 12 months. With dividends included, the 12-month total return was -87.4%.
How has NMRA stock done over the long term?
Neumora Therapeutics's month-end price fell 96.6% over the 3 years through Oct 2026, a compound annual decline of 67.7%. These figures leave out dividends.
What is NMRA's 52-week high and low?
Neumora Therapeutics's 52-week high is $3.65 and its 52-week low is $0.32. Its latest price of $0.33 on Nov 17, 2026 is 90.8% below the high.
What is NMRA's beta?
Neumora Therapeutics's 1-year beta against the S&P 500 is 0.74, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 90.7%.
Is the NMRA chart free?
Yes. Advanced Charting for NMRA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NMRA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors